Alias
科研级 Lexatumumab ( 来沙木单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab
Molecular Name
Lexatumumab
Applications
ELISA, IP, FC, FuncS, Neut, IF
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
TNFRSF10B/CD262[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。